NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Inrobics

Inrobics

Private
MadridHealthcare & Life Scienceshttps://inrobics.com/

Last Round

VC Round

Jul 9, 2026

Est. Valuation

$1.38M

Total Funding Raised

$350,000

Company Overview

Inrobics is a digital health company that provides a platform with personalized rehabilitation services through social robots and artificial intelligence for individuals with functional or neurological limitations.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Telemedicine, Patient Engagement

Business Model

B2B

Customer Profile

Subscription SaaS, Hardware + Subscription

AI Layer

Application

Keywords

social roboticsneurorehabilitationphysical therapyrehab roboticstelerehabilitationrobot therapyhumanoid robotAI-powered therapydigital healthgamified therapyskeleton trackingtelehealthSaaSmedical devicepatient monitoring

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Inrobics Comps

Public and private peers based on sector, stage, and business model.

Inrobics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Inrobics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJul 9, 2026
Early FundingMar 18, 2024
SeedAug 8, 2022
AngelJun 24, 2021

Key People

Founding team and executive leadership

Fernando Fernández

Chief Scientific Officer And Founder

Founding Team

José Carlos González Dorado

Founder CTO

Founding Team

José Carlos Pulido Pascual

Founder & CEO

Founding Team

Inrobics Investors

Notable investors and investment history

Inrobics investors
InvestorRounds
StartupxploreVC Round
Grow Venture PartnersSeed, VC Round
Cell CapitalSeed
Capital CellSeed

Inrobics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Inrobics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Inrobics's valuation, stock price, and market status.

Firmographic Details

HeadquartersMadrid
Employee Range15
Year Founded2020
Last FundingJul 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.